Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
04 2023
Historique:
medline: 1 5 2023
pubmed: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

We investigated choroid plexus (CP) volume in patients presenting with optic neuritis (ON) as a clinically isolated syndrome (CIS), compared to a cohort with established relapsing-remitting multiple sclerosis (RRMS) and healthy controls (HCs). Three-dimensional (3D) T1, T2-FLAIR and diffusion-weighted sequences were acquired from 44 ON CIS patients at baseline, 1, 3, 6 and 12 months after the onset of ON. Fifty RRMS patients and 50 HCs were also included for comparison. CP volumes was larger in both ON CIS and RRMS groups compared to HCs, but not significantly different between ON CIS and RRMS patients (analysis of covariance (ANCOVA) adjusted for multiple comparisons). Twenty-three ON CIS patients who converted to clinically definite MS (MS) demonstrated CP volume similar to RRMS patients, but significantly larger compared to HCs. In this sub-group, CP volume was not associated with the severity of optic nerve inflammation or long-term axonal loss, not with brain lesion load. A transient increase of CP volume was observed following an occurrence of new MS lesions on brain magnetic resonance imaging (MRI). Enlarged CP can be observed very early in a disease. It transiently reacts to acute inflammation, but not associated with the degree of tissue destruction.

Identifiants

pubmed: 36876595
doi: 10.1177/13524585231157206
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

540-548

Auteurs

Samuel Klistorner (S)

Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

Anneke Van der Walt (A)

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaScott Kolbe Monash University, Melbourne, VIC, Australia.

Michael H Barnett (MH)

Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia/Sydney Neuroimaging Analysis Centre, Camperdown, NSW, Australia.

Helmut Butzkueven (H)

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.

Scott Kolbe (S)

Monash University, Melbourne, VIC, Australia.

John Parratt (J)

Royal North Shore Hospital, Sydney, NSW, Australia.

Con Yiannikas (C)

Royal North Shore Hospital, Sydney, NSW, Australia.

Alexander Klistorner (A)

Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH